Combination therapy as a strategy to prevent antimalarial drug resistance.

Pamela Orjuela, Iveth González, Lyda Osorio, .

Keywords: malaria, Plasmodium falciparum, antimaláricos, resistencia, terapia combinada, artemisinina

Abstract

Resistance of Plasmodium falciparum to antimalarials is considered one of the factors responsible for the impairment of the malaria treatment and control worldwide. Resistance emerges as a result of selection and then disemination of spontaneous mutant parasites with reduced drug susceptibility. Combination therapy is considered as the main strategy to control antimalarial drug resistance. Currently, combination therapies that include artemisinin derivatives are highly recommended. Combination therapy has been used in Colombia for more than 20 years; however, its impact on preventing the dissemination of drug resistance is unknown. This paper reviews the theoretical bases and clinical studies that support the use of combination therapy.

Downloads

Download data is not yet available.
  • Pamela Orjuela Centro Internacional de Entrenamiento e Investigaciones Médicas, CIDEIM, Cali, Colombia.
  • Iveth González Centro Internacional de Entrenamiento e Investigaciones Médicas, CIDEIM, Cali
  • Lyda Osorio Centro Internacional de Entrenamiento e Investigaciones Médicas, CIDEIM, Cali
How to Cite
1.
Orjuela P, González I, Osorio L. Combination therapy as a strategy to prevent antimalarial drug resistance. biomedica [Internet]. 2004 Dec. 1 [cited 2024 May 21];24(4):423-37. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/1292

Some similar items:

Published
2004-12-01
Section
Topic review

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code